The Synthesis and Secretion of Inhibins

Vitamins and Hormones

Volumn 85, Issue , 2011, Pages 149-184

  Walton, Kelly L ^a   Makanji, Yogeshwar ^a   Robertson, David M ^a   Harrison, Craig A ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Activin; Follicle stimulating hormone; Gonadotrophins; Inhibin; Ligand synthesis; Prodomain; Signaling; Transcriptional activation; Transforming growth factor

Indexed keywords

EID: 79951906630     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385961-7.00008-1     Document Type: Book

References (206)

1. Alexander J.M., Bikkal H.A., Zervas N.T., Laws E.R., Klibanski A. Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas. J. Clin. Endocrinol. Metab. 1996, 81:783-790.
2. Ambros V. microRNAs: Tiny regulators with great potential. Cell 2001, 107:823-826.
3. Anderson R.A., Cambray N., Hartley P.S., McNeilly A.S. Expression and localization of inhibin alpha, inhibin/activin betaA and betaB and the activin type II and inhibin beta-glycan receptors in the developing human testis. Reproduction 2002, 123:779-788.
4. Annes J.P., Munger J.S., Rifkin D.B. Making sense of latent TGFbeta activation. J. Cell Sci. 2003, 116:217-224.
5. Antenos M., Stemler M., Boime I., Woodruff T.K. N-linked oligosaccharides direct the differential assembly and secretion of inhibin alpha- and betaA-subunit dimers. Mol. Endocrinol. 2007, 21:1670-1684.
6. Antenos M., Zhu J., Jetly N.M., Woodruff T.K. An activin/furin regulatory loop modulates the processing and secretion of inhibin alpha- and betaB-subunit dimers in pituitary gonadotrope cells. J. Biol. Chem. 2008, 283:33059-33068.
7. Ardekani A.M., Romanelli J.C., Mayo K.E. Structure of the rat inhibin and activin betaA-subunit gene and regulation in an ovarian granulosa cell line. Endocrinology 1998, 139:3271-3279.
8. Attardi B., Miklos J. Rapid stimulatory effect of activin-A on messenger RNA encoding the follicle-stimulating hormone beta-subunit in rat pituitary cell cultures. Mol. Endocrinol. 1990, 4:721-726.
9. Attardi B., Vaughan J., Vale W. Regulation of FSH beta messenger ribonucleic acid levels in the rat by endogenous inhibin. Endocrinology 1992, 130:557-559.
10. Ay E., Kavak Z.N., Elter K., Gokaslan H., Pekin T. Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy. Aust. NZ J. Obstet. Gynaecol. 2005, 45:283-288.
11. Balanathan P., Ball E.M., Wang H., Harris S.E., Shelling A.N., Risbridger G.P. Epigenetic regulation of inhibin alpha-subunit gene in prostate cancer cell lines. J. Mol. Endocrinol. 2004, 32:55-67.
12. Barton D.E., Yang-Feng T.L., Mason A.J., Seeburg P.H., Francke U. Mapping of genes for inhibin subunits alpha, beta A, and beta B on human and mouse chromosomes and studies of jsd mice. Genomics 1989, 5:91-99.
13. Bersinger N.A., Smarason A.K., Muttukrishna S., Groome N.P., Redman C.W. Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A and soluble E-selectin. Hypertens. Pregnancy 2003, 22:45-55.
14. Bhasin S., Krummen L.A., Swerdloff R.S., Morelos B.S., Kim W.H., diZerega G.S., Ling N., Esch F., Shimasaki S., Toppari J. Stage dependent expression of inhibin alpha and beta-B subunits during the cycle of the rat seminiferous epithelium. Endocrinology 1989, 124:987-991.
15. Bicsak T.A., Tucker E.M., Cappel S., Vaughan J., Rivier J., Vale W., Hsueh A.J. Hormonal regulation of granulosa cell inhibin biosynthesis. Endocrinology 1986, 119:2711-2719.
16. Bicsak T.A., Vale W., Vaughan J., Tucker E.M., Cappel S., Hsueh A.J. Hormonal regulation of inhibin production by cultured Sertoli cells. Mol. Cell. Endocrinol. 1987, 49:211-217.
17. Bilandzic M., Chu S., Farnworth P.G., Harrison C., Nicholls P., Wang Y., Escalona R.M., Fuller P.J., Findlay J.K., Stenvers K.L. Loss of betaglycan contributes to the malignant properties of human granulosa tumor cells. Mol. Endocrinol. 2009, 23:539-548.
18. Blanchet M.H., Le Good J.A., Mesnard D., Oorschot V., Baflast S., Minchiotti G., Klumperman J., Constam D.B. Cripto recruits Furin and PACE4 and controls Nodal trafficking during proteolytic maturation. EMBO J. 2008, 27:2580-2591.
19. Boitani C., Stefanini M., Fragale A., Morena A.R. Activin stimulates Sertoli cell proliferation in a defined period of rat testis development. Endocrinology 1995, 136:5438-5444.
20. Bondestam J., Kaivo-oja N., Kallio J., Groome N., Hyden-Granskog C., Fujii M., Moustakas A., Jalanko A., ten Dijke P., Ritvos O. Engagement of activin and bone morphogenetic protein signaling pathway Smad proteins in the induction of inhibin B production in ovarian granulosa cells. Mol. Cell. Endocrinol. 2002, 195:79-88.
21. Bottinger E.P., Factor V.M., Tsang M.L., Weatherbee J.A., Kopp J.B., Qian S.W., Wakefield L.M., Roberts A.B., Thorgeirsson S.S., Sporn M.B. The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice. Proc. Natl. Acad. Sci. USA 1996, 93:5877-5882.
22. Brunner A.M., Marquardt H., Malacko A.R., Lioubin M.N., Purchio A.F. Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor beta 1 precursor. Expression and characterization of mutant proteins. J. Biol. Chem. 1989, 264:13660-13664.
23. Brunner A.M., Lioubin M.N., Marquardt H., Malacko A.R., Wang W.C., Shapiro R.A., Neubauer M., Cook J., Madisen L., Purchio A.F. Site-directed mutagenesis of glycosylation sites in the transforming growth factor-beta 1 (TGF beta 1) and TGF beta 2 (414) precursors and of cysteine residues within mature TGF beta 1: Effects on secretion and bioactivity. Mol. Endocrinol. 1992, 6:1691-1700.
24. Burger H.G., Robertson D.M., Cahir N., Mamers P., Healy D.L., Jobling T., Groome N. Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumours. Clin. Endocrinol. (Oxf) 1996, 44:413-418.
25. Burger H.G., Cahir N., Robertson D.M., Groome N.P., Dudley E., Green A., Dennerstein L. Serum inhibins A and B fall differentially as FSH rises in perimenopausal women. Clin. Endocrinol. (Oxf) 1998, 48:809-813.
26. Burger H.G., Groome N.P., Robertson D.M. Both inhibin A and B respond to exogenous follicle-stimulating hormone in the follicular phase of the human menstrual cycle. J. Clin. Endocrinol. Metab. 1998, 83:4167-4169.
27. Burger H.G., Fuller P.J., Chu S., Mamers P., Drummond A., Susil B., Neva P., Robertson D.M. The inhibins and ovarian cancer. Mol. Cell. Endocrinol. 2001, 180:145-148.
28. Burkart A.D., Mukherjee A., Sterneck E., Johnson P.F., Mayo K.E. Repression of the inhibin alpha-subunit gene by the transcription factor CCAAT/enhancer-binding protein-beta. Endocrinology 2005, 146:1909-1921.
29. Buzzard J.J., Loveland K.L., O'Bryan M.K., O'Connor A.E., Bakker M., Hayashi T., Wreford N.G., Morrison J.R., de Kretser D.M. Changes in circulating and testicular levels of inhibin A and B and activin A during postnatal development in the rat. Endocrinology 2004, 145:3532-3541.
30. Carroll R.S., Corrigan A.Z., Gharib S.D., Vale W., Chin W.W. Inhibin, activin, and follistatin: Regulation of follicle-stimulating hormone messenger ribonucleic acid levels. Mol. Endocrinol. 1989, 3:1969-1976.
31. Casagrandi D., Bearfield C., Geary J., Redman C.W., Muttukrishna S. Inhibin, activin, follistatin, activin receptors and beta-glycan gene expression in the placental tissue of patients with pre-eclampsia. Mol. Hum. Reprod. 2003, 9:199-203.
32. Centrella M., Horowitz M.C., Wozney J.M., McCarthy T.L. Transforming growth factor-beta gene family members and bone. Endocr. Rev. 1994, 15:27-39.
33. Chen C.C., Johnson P.A. Expression of inhibin alpha and inhibin/activin beta A subunits in the granulosa layer of the large preovulatory follicles of the hen. Biol. Reprod. 1996, 55:450-454.
34. Ciarmela P., Florio P., Toti P., Franchini A., Maguer-Satta V., Ginanneschi C., Ottaviani E., Petraglia F. Human placenta and fetal membranes express follistatin-related gene mRNA and protein. J. Endocrinol. Invest. 2003, 26:641-645.
35. Corrigan A.Z., Bilezikjian L.M., Carroll R.S., Bald L.N., Schmelzer C.H., Fendly B.M., Mason A.J., Chin W.W., Schwall R.H., Vale W. Evidence for an autocrine role of activin B within rat anterior pituitary cultures. Endocrinology 1991, 128:1682-1684.
36. Coss D., Thackray V.G., Deng C.X., Mellon P.L. Activin regulates luteinizing hormone beta-subunit gene expression through Smad-binding and homeobox elements. Mol. Endocrinol. 2005, 19:2610-2623.
37. De Crescenzo G., Grothe S., Zwaagstra J., Tsang M., O'Connor-McCourt M.D. Real-time monitoring of the interactions of transforming growth factor-beta (TGF-beta ) isoforms with latency-associated protein and the ectodomains of the TGF-beta type II and III receptors reveals different kinetic models and stoichiometries of binding. J. Biol. Chem. 2001, 276:29632-29643.
38. Dennler S., Itoh S., Vivien D., ten Dijke P., Huet S., Gauthier J.M. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 1998, 17:3091-3100.
39. DePaolo L.V., Bicsak T.A., Erickson G.F., Shimasaki S., Ling N. Follistatin and activin: A potential intrinsic regulatory system within diverse tissues. Proc. Soc. Exp. Biol. Med. 1991, 198:500-512.
40. Derynck R., Zhang Y., Feng X.H. Smads: Transcriptional activators of TGF-beta responses. Cell 1998, 95:737-740.
41. Di Loreto C., Reis F.M., Cataldi P., Zuiani C., Luisi S., Beltrami C.A., Petraglia F. Human mammary gland and breast carcinoma contain immunoreactive inhibin/activin subunits: Evidence for a secretion into cystic fluid. Eur. J. Endocrinol. 1999, 141:190-194.
42. Drummond A.E., Le M.T., Ethier J.F., Dyson M., Findlay J.K. Expression and localization of activin receptors, Smads, and beta glycan to the postnatal rat ovary. Endocrinology 2002, 143:1423-1433.
43. Dykema J.C., Mayo K.E. Two messenger ribonucleic acids encoding the common beta B-chain of inhibin and activin have distinct 5'-initiation sites and are differentially regulated in rat granulosa cells. Endocrinology 1994, 135:702-711.
44. Edwards S.J., Reader K.L., Lun S., Western A., Lawrence S., McNatty K.P., Juengel J.L. The cooperative effect of growth and differentiation factor-9 and bone morphogenetic protein (BMP)-15 on granulosa cell function is modulated primarily through BMP receptor II. Endocrinology 2008, 149:1026-1030.
45. Eramaa M., Ritvos O. Transforming growth factor-beta 1 and -beta 2 induce inhibin and activin beta B-subunit messenger ribonucleic acid levels in cultured human granulosa-luteal cells. Fertil. Steril. 1996, 65:954-960.
46. Eramaa M., Hilden K., Tuuri T., Ritvos O. Regulation of inhibin/activin subunit messenger ribonucleic acids (mRNAs) by activin A and expression of activin receptor mRNAs in cultured human granulosa-luteal cells. Endocrinology 1995, 136:4382-4389.
47. Feng Z.M., Li Y.P., Chen C.L. Analysis of the 5'-flanking regions of rat inhibin alpha- and beta-B-subunit genes suggests two different regulatory mechanisms. Mol. Endocrinol. 1989, 3:1914-1925.
48. Feng Z.M., Wu A.Z., Chen C.L. Characterization and regulation of two testicular inhibin/activin beta B-subunit messenger ribonucleic acids that are transcribed from alternate initiation sites. Endocrinology 1995, 136:947-955.
49. Florio P., Luisi S., D'Antona D., Severi F.M., Rago G., Petraglia F. Maternal serum inhibin A levels may predict pregnancy outcome in women with threatened abortion. Fertil. Steril. 2004, 81:468-470.
50. Gleizes P.E., Beavis R.C., Mazzieri R., Shen B., Rifkin D.B. Identification and characterization of an eight-cysteine repeat of the latent transforming growth factor-beta binding protein-1 that mediates bonding to the latent transforming growth factor-beta1. J. Biol. Chem. 1996, 271:29891-29896.
51. Good T.E., Weber P.S., Ireland J.L., Pulaski J., Padmanabhan V., Schneyer A.L., Lambert-Messerlian G., Ghosh B.R., Miller W.L., Groome N., et al. Isolation of nine different biologically and immunologically active molecular variants of bovine follicular inhibin. Biol. Reprod. 1995, 53:1478-1488.
52. Gray A.M., Mason A.J. Requirement for activin A and transforming growth factor-beta 1 pro-regions in homodimer assembly. Science 1990, 247:1328-1330.
53. Groome N. Ultrasensitive two-site assays for inhibin-A and activin-A using monoclonal antibodies raised to synthetic peptides. J. Immunol. Methods 1991, 145:65-69.
54. Groome N., Lawrence M. Preparation of monoclonal antibodies to the beta A subunit of ovarian inhibin using a synthetic peptide immunogen. Hybridoma 1991, 10:309-316.
55. Groome N., Hancock J., Betteridge A., Lawrence M., Craven R. Monoclonal and polyclonal antibodies reactive with the 1-32 amino terminal sequence of the alpha subunit of human 32K inhibin. Hybridoma 1990, 9:31-42.
56. Groome N.P., Illingworth P.J., O'Brien M., Pai R., Rodger F.E., Mather J.P., McNeilly A.S. Measurement of dimeric inhibin B throughout the human menstrual cycle. J. Clin. Endocrinol. Metab. 1996, 81:1401-1405.
57. Grootenhuis A.J., Timmerman M.A., Hordijk P.L., de Jong F.H. Inhibin in immature rat Sertoli cell conditioned medium: A 32 kDa alpha beta-B dimer. Mol. Cell. Endocrinol. 1990, 70:109-116.
58. Grootenhuis A.J., van Beurden W.M., Timmerman M.A., de Jong F.H. Follicle-stimulating hormone-stimulated secretion of an immunoreactive 29 kDa inhibin alpha-subunit complex, but not of 32 kDa bioactive inhibin, from cultured immature rat Sertoli cells. Mol. Cell. Endocrinol. 1990, 74:125-132.
59. Groppe J., Hinck C.S., Samavarchi-Tehrani P., Zubieta C., Schuermann J.P., Taylor A.B., Schwarz P.M., Wrana J.L., Hinck A.P. Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding. Mol. Cell 2008, 29:157-168.
60. Haddad G., Penabad J.L., Bashey H.M., Asa S.L., Gennarelli T.A., Cirullo R., Snyder P.J. Expression of activin/inhibin subunit messenger ribonucleic acids by gonadotroph adenomas. J. Clin. Endocrinol. Metab. 1994, 79:1399-1403.
61. Hancock A.D., Robertson D.M., de Kretser D.M. Inhibin and inhibin alpha-chain precursors are produced by immature rat Sertoli cells in culture. Biol. Reprod. 1992, 46:155-161.
62. Hart P.J., Deep S., Taylor A.B., Shu Z., Hinck C.S., Hinck A.P. Crystal structure of the human TbetaR2 ectodomain-TGF-beta3 complex. Nat. Struct. Biol. 2002, 9:203-208.
63. He W.W., Gustafson M.L., Hirobe S., Donahoe P.K. Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-beta type II receptor family. Dev. Dyn. 1993, 196:133-142.
64. Healy D.L., Burger H.G., Mamers P., Jobling T., Bangah M., Quinn M., Grant P., Day A.J., Rome R., Campbell J.J. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. N. Engl. J. Med. 1993, 329:1539-1542.
65. Hempel N., How T., Dong M., Murphy S.K., Fields T.A., Blobe G.C. Loss of betaglycan expression in ovarian cancer: Role in motility and invasion. Cancer Res. 2007, 67:5231-5238.
66. Husken-Hindi P., Tsuchida K., Park M., Corrigan A.Z., Vaughan J.M., Vale W.W., Fischer W.H. Monomeric activin A retains high receptor binding affinity but exhibits low biological activity. J. Biol. Chem. 1994, 269:19380-19384.
67. Illingworth P.J., Groome N.P., Byrd W., Rainey W.E., McNeilly A.S., Mather J.P., Bremner W.J. Inhibin-B: A likely candidate for the physiologically important form of inhibin in men. J. Clin. Endocrinol. Metab. 1996, 81:1321-1325.
68. Ireland J.L., Good T.E., Knight P.G., Ireland J.J. Alterations in amounts of different forms of inhibin during follicular atresia. Biol. Reprod. 1994, 50:1265-1276.
69. Ito M., Park Y., Weck J., Mayo K.E., Jameson J.L. Synergistic activation of the inhibin alpha-promoter by steroidogenic factor-1 and cyclic adenosine 3', 5'-monophosphate. Mol. Endocrinol. 2000, 14:66-81.
70. Jaatinen R., Bondestam J., Raivio T., Hilden K., Dunkel L., Groome N., Ritvos O. Activation of the bone morphogenetic protein signaling pathway induces inhibin beta(B)-subunit mRNA and secreted inhibin B levels in cultured human granulosa-luteal cells. J. Clin. Endocrinol. Metab. 2002, 87:1254-1261.
71. Jeruss J.S., Santiago J.Y., Woodruff T.K. Localization of activin and inhibin subunits, receptors and SMADs in the mouse mammary gland. Mol. Cell. Endocrinol. 2003, 203:185-196.
72. Jones R.L., Salamonsen L.A., Critchley H.O., Rogers P.A., Affandi B., Findlay J.K. Inhibin and activin subunits are differentially expressed in endometrial cells and leukocytes during the menstrual cycle, in early pregnancy and in women using progestin-only contraception. Mol. Hum. Reprod. 2000, 6:1107-1117.
73. Jones R.L., Salamonsen L.A., Findlay J.K. Potential roles for endometrial inhibins, activins and follistatin during human embryo implantation and early pregnancy. Trends Endocrinol. Metab. 2002, 13:144-150.
74. Jones R.L., Salamonsen L.A., Zhao Y.C., Ethier J.F., Drummond A.E., Findlay J.K. Expression of activin receptors, follistatin and betaglycan by human endometrial stromal cells; consistent with a role for activins during decidualization. Mol. Hum. Reprod. 2002, 8:363-374.
75. Jones R.L., Findlay J.K., Farnworth P.G., Robertson D.M., Wallace E., Salamonsen L.A. Activin A and inhibin A differentially regulate human uterine matrix metalloproteinases: Potential interactions during decidualization and trophoblast invasion. Endocrinology 2006, 147:724-732.
76. Kaipia A., Parvinen M., Shimasaki S., Ling N., Toppari J. Stage-specific cellular regulation of inhibin alpha-subunit mRNA expression in the rat seminiferous epithelium. Mol. Cell. Endocrinol. 1991, 82:165-173.
77. Kaiser U.B., Lee B.L., Carroll R.S., Unabia G., Chin W.W., Childs G.V. Follistatin gene expression in the pituitary: Localization in gonadotropes and folliculostellate cells in diestrous rats. Endocrinology 1992, 130:3048-3056.
78. Kaivo-Oja N., Bondestam J., Kamarainen M., Koskimies J., Vitt U., Cranfield M., Vuojolainen K., Kallio J.P., Olkkonen V.M., Hayashi M., Moustakas A., Groome N.P., et al. Growth differentiation factor-9 induces Smad2 activation and inhibin B production in cultured human granulosa-luteal cells. J. Clin. Endocrinol. Metab. 2003, 88:755-762.
79. Kingsley D.M. The TGF-beta superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 1994, 8:133-146.
80. Klein N.A., Illingworth P.J., Groome N.P., McNeilly A.S., Battaglia D.E., Soules M.R. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: A study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J. Clin. Endocrinol. Metab. 1996, 81:2742-2745.
81. Knight P.G., Glister C. TGF-beta superfamily members and ovarian follicle development. Reproduction 2006, 132:191-206.
82. Knight P.G., Beard A.J., Wrathall J.H., Castillo R.J. Evidence that the bovine ovary secretes large amounts of monomeric inhibin alpha subunit and its isolation from bovine follicular fluid. J. Mol. Endocrinol. 1989, 2:189-200.
83. La Rosa S., Uccella S., Billo P., Facco C., Sessa F., Capella C. Immunohistochemical localization of alpha- and betaA-subunits of inhibin/activin in human normal endocrine cells and related tumors of the digestive system. Virchows Arch. 1999, 434:29-36.
84. La Rosa S., Uccella S., Marchet S., Capella C., Lloyd R.V. Localization of inhibins and activins in normal endocrine cells and endocrine tumors of the gut and pancreas: An immunohistochemical and in situ hybridization study. J. Histochem. Cytochem. 2004, 52:217-225.
85. Lappohn R.E., Burger H.G., Bouma J., Bangah M., Krans M., de Bruijn H.W. Inhibin as a marker for granulosa-cell tumors. N. Engl. J. Med. 1989, 321:790-793.
86. Leung P.H., Salamonsen L.A., Findlay J.K. Immunolocalization of inhibin and activin subunits in human endometrium across the menstrual cycle. Hum. Reprod. 1998, 13:3469-3477.
87. Leversha L.J., Robertson D.M., de Vos F.L., Morgan F.J., Hearn M.T., Wettenhall R.E., Findlay J.K., Burger H.G., de Kretser D.M. Isolation of inhibin from ovine follicular fluid. J. Endocrinol. 1987, 113:213-221.
88. Lewis K.A., Gray P.C., Blount A.L., MacConell L.A., Wiater E., Bilezikjian L.M., Vale W. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature 2000, 404:411-414.
89. Ling N., Ying S.Y., Ueno N., Esch F., Denoroy L., Guillemin R. Isolation and partial characterization of a Mr 32, 000 protein with inhibin activity from porcine follicular fluid. Proc. Natl. Acad. Sci. USA 1985, 82:7217-7221.
90. Ludlow H., Muttukrishna S., Hyvonen M., Groome N.P. Development of a new antibody to the human inhibin/activin betaB subunit and its application to improved inhibin B ELISAs. J. Immunol. Methods 2008, 329:102-111.
91. Ludlow H., Phillips D.J., Myers M., McLachlan R.I., de Kretser D.M., Allan C.A., Anderson R.A., Groome N.P., Hyvonen M., Colin Duncan W., Muttukrishna S. A new 'total' activin B enzyme-linked immunosorbent assay (ELISA): Development and validation for human samples. Clin. Endocrinol. (Oxf) 2009, 71:867-873.
92. MacConell L.A., Leal A.M., Vale W.W. The distribution of betaglycan protein and mRNA in rat brain, pituitary, and gonads: Implications for a role for betaglycan in inhibin-mediated reproductive functions. Endocrinology 2002, 143:1066-1075.
93. Madazli R., Kuseyrioglu B., Uzun H., Uludag S., Ocak V. Prediction of preeclampsia with maternal mid-trimester placental growth factor, activin A, fibronectin and uterine artery Doppler velocimetry. Int. J. Gynaecol. Obstet. 2005, 89:251-257.
94. Majdic G., McNeilly A.S., Sharpe R.M., Evans L.R., Groome N.P., Saunders P.T. Testicular expression of inhibin and activin subunits and follistatin in the rat and human fetus and neonate and during postnatal development in the rat. Endocrinology 1997, 138:2136-2147.
95. Majumdar S.S., Winters S.J., Plant T.M. A study of the relative roles of follicle-stimulating hormone and luteinizing hormone in the regulation of testicular inhibin secretion in the rhesus monkey (Macaca mulatta). Endocrinology 1997, 138:1363-1373.
96. Makanji Y., Harrison C.A., Stanton P.G., Krishna R., Robertson D.M. Inhibin A and B in vitro bioactivities are modified by their degree of glycosylation and their affinities to betaglycan. Endocrinology 2007, 148:2309-2316.
97. Malone F.D., Canick J.A., Ball R.H., Nyberg D.A., Comstock C.H., Bukowski R., Berkowitz R.L., Gross S.J., Dugoff L., Craigo S.D., Timor-Tritsch I.E., Carr S.R., et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N. Engl. J. Med. 2005, 353:2001-2011.
98. Marchetti C., Hamdane M., Mitchell V., Mayo K., Devisme L., Rigot J.M., Beauvillain J.C., Hermand E., Defossez A. Immunolocalization of inhibin and activin alpha and betaB subunits and expression of corresponding messenger RNAs in the human adult testis. Biol. Reprod. 2003, 68:230-235.
99. Martins da Silva S.J., Bayne R.A., Cambray N., Hartley P.S., McNeilly A.S., Anderson R.A. Expression of activin subunits and receptors in the developing human ovary: Activin A promotes germ cell survival and proliferation before primordial follicle formation. Dev. Biol. 2004, 266:334-345.
100. Mason A.J., Hayflick J.S., Ling N., Esch F., Ueno N., Ying S.Y., Guillemin R., Niall H., Seeburg P.H. Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-beta. Nature 1985, 318:659-663.
101. Mason A.J., Niall H.D., Seeburg P.H. Structure of two human ovarian inhibins. Biochem. Biophys. Res. Commun. 1986, 135:957-964.
102. Mason A.J., Berkemeier L.M., Schmelzer C.H., Schwall R.H. Activin B: Precursor sequences, genomic structure and in vitro activities. Mol. Endocrinol. 1989, 3:1352-1358.
103. Mason A.J., Farnworth P.G., Sullivan J. Characterization and determination of the biological activities of noncleavable high molecular weight forms of inhibin A and activin A. Mol. Endocrinol. 1996, 10:1055-1065.
104. Massague J., Cheifetz S., Boyd F.T., Andres J.L. TGF-beta receptors and TGF-beta binding proteoglycans: Recent progress in identifying their functional properties. Ann. NY Acad. Sci. 1990, 593:59-72.
105. Mather J.P., Attie K.M., Woodruff T.K., Rice G.C., Phillips D.M. Activin stimulates spermatogonial proliferation in germ-Sertoli cell cocultures from immature rat testis. Endocrinology 1990, 127:3206-3214.
106. Mathews L.S., Vale W.W. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 1991, 65:973-982.
107. Matsuzaki K., Xu J., Wang F., McKeehan W.L., Krummen L., Kan M. A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor beta, or bone morphogenic factor. J. Biol. Chem. 1993, 268:12719-12723.
108. Matzuk M.M., Finegold M.J., Su J.G., Hsueh A.J., Bradley A. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 1992, 360:313-319.
109. Matzuk M.M., Finegold M.J., Mather J.P., Krummen L., Lu H., Bradley A. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc. Natl. Acad. Sci. USA 1994, 91:8817-8821.
110. McLachlan R.I., Robertson D.M., Burger H.G., de Kretser D.M. The radioimmunoassay of bovine and human follicular fluid and serum inhibin. Mol. Cell. Endocrinol. 1986, 46:175-185.
111. McMahon H.E., Sharma S., Shimasaki S. Phosphorylation of bone morphogenetic protein-15 and growth and differentiation factor-9 plays a critical role in determining agonistic or antagonistic functions. Endocrinology 2008, 149:812-817.
112. Mellor S.L., Richards M.G., Pedersen J.S., Robertson D.M., Risbridger G.P. Loss of the expression and localization of inhibin alpha-subunit in high grade prostate cancer. J. Clin. Endocrinol. Metab. 1998, 83:969-975.
113. Meunier H., Rivier C., Evans R.M., Vale W. Gonadal and extragonadal expression of inhibin alpha, beta A, and beta B subunits in various tissues predicts diverse functions. Proc. Natl. Acad. Sci. USA 1988, 85:247-251.
114. Miyamoto K., Hasegawa Y., Fukuda M., Nomura M., Igarashi M., Kangawa K., Matsuo H. Isolation of porcine follicular fluid inhibin of 32K daltons. Biochem. Biophys. Res. Commun. 1985, 129:396-403.
115. Miyamoto K., Hasegawa Y., Fukuda M., Igarashi M. Demonstration of high molecular weight forms of inhibin in bovine follicular fluid (bFF) by using monoclonal antibodies to bFF 32K inhibin. Biochem. Biophys. Res. Commun. 1986, 136:1103-1109.
116. Miyazono K., Hellman U., Wernstedt C., Heldin C.H. Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization. J. Biol. Chem. 1988, 263:6407-6415.
117. Molloy S.S., Anderson E.D., Jean F., Thomas G. Bi-cycling the furin pathway: From TGN localization to pathogen activation and embryogenesis. Trends Cell Biol. 1999, 9:28-35.
118. Moore K.H., Dunbar B.S., Bousfield G.R., Ward D.N. Initial characterization of equine inhibin. Biol. Reprod. 1994, 51:63-71.
119. Mukherjee A., Park-Sarge O.K., Mayo K.E. Gonadotropins induce rapid phosphorylation of the 3', 5'-cyclic adenosine monophosphate response element binding protein in ovarian granulosa cells. Endocrinology 1996, 137:3234-3245.
120. Mukherjee A., Urban J., Sassone-Corsi P., Mayo K.E. Gonadotropins regulate inducible cyclic adenosine 3', 5'-monophosphate early repressor in the rat ovary: Implications for inhibin alpha subunit gene expression. Mol. Endocrinol. 1998, 12:785-800.
121. Muttukrishna S., George L., Fowler P.A., Groome N.P., Knight P.G. Measurement of serum concentrations of inhibin-A (alpha-beta A dimer) during human pregnancy. Clin. Endocrinol. (Oxf) 1995, 42:391-397.
122. Muttukrishna S., Bearfield C., Johns J., Jauniaux E. Inhibin, activin, follistatin, activin receptors and beta-glycan gene expression in the villous tissue of miscarriage patients. Mol. Hum. Reprod. 2004, 10:793-798.
123. Nakayama K. Furin: A mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem. J. 1997, 327(Pt 3):625-635.
124. Noguchi J., Hikono H., Sato S., Watanabe G., Taya K., Sasamoto S., Hasegawa Y. Ontogeny of inhibin secretion in the rat testis: Secretion of inhibin-related proteins from fetal Leydig cells and of bioactive inhibin from Sertoli cells. J. Endocrinol. 1997, 155:27-34.
125. Ohga E., Matsuse T., Teramoto S., Ouchi Y. Activin receptors are expressed on human lung fibroblast and activin A facilitates fibroblast-mediated collagen gel contraction. Life Sci. 2000, 66:1603-1613.
126. Okuma Y., O'Connor A.E., Hayashi T., Loveland K.L., de Kretser D.M., Hedger M.P. Regulated production of activin A and inhibin B throughout the cycle of the seminiferous epithelium in the rat. J. Endocrinol. 2006, 190:331-340.
127. Pangas S.A., Rademaker A.W., Fishman D.A., Woodruff T.K. Localization of the activin signal transduction components in normal human ovarian follicles: Implications for autocrine and paracrine signaling in the ovary. J. Clin. Endocrinol. Metab. 2002, 87:2644-2657.
128. Pei L., Dodson R., Schoderbek W.E., Maurer R.A., Mayo K.E. Regulation of the alpha inhibin gene by cyclic adenosine 3', 5'-monophosphate after transfection into rat granulosa cells. Mol. Endocrinol. 1991, 5:521-534.
129. Penabad J.L., Bashey H.M., Asa S.L., Haddad G., Davis K.D., Herbst A.B., Gennarelli T.A., Kaiser U.B., Chin W.W., Snyder P.J. Decreased follistatin gene expression in gonadotroph adenomas. J. Clin. Endocrinol. Metab. 1996, 81:3397-3403.
130. Petraglia F., Vaughan J., Vale W. Inhibin and activin modulate the release of gonadotropin-releasing hormone, human chorionic gonadotropin, and progesterone from cultured human placental cells. Proc. Natl. Acad. Sci. USA 1989, 86:5114-5117.
131. Petraglia F., Calza L., Garuti G.C., Abrate M., Giardino L., Genazzani A.R., Vale W., Meunier H. Presence and synthesis of inhibin subunits in human decidua. J. Clin. Endocrinol. Metab. 1990, 71:487-492.
132. Petraglia F., Florio P., Luisi S., Gallo R., Gadducci A., Vigano P., Di Blasio A.M., Genazzani A.R., Vale W. Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues. High levels of serum activin A in women with endometrial and cervical carcinoma. J. Clin. Endocrinol. Metab. 1998, 83:1194-1200.
133. Qu J., Thomas K. Inhibin and activin production in human placenta. Endocr. Rev. 1995, 16:485-507.
134. Reame N.E., Wyman T.L., Phillips D.J., de Kretser D.M., Padmanabhan V. Net increase in stimulatory input resulting from a decrease in inhibin B and an increase in activin A may contribute in part to the rise in follicular phase follicle-stimulating hormone of aging cycling women. J. Clin. Endocrinol. Metab. 1998, 83:3302-3307.
135. Reis F.M., Cobellis L., Tameirao L.C., Anania G., Luisi S., Silva I.S., Gioffre W., Di Blasio A.M., Petraglia F. Serum and tissue expression of activin a in postmenopausal women with breast cancer. J. Clin. Endocrinol. Metab. 2002, 87:2277-2282.
136. Reis F.M., Luisi S., Carneiro M.M., Cobellis L., Federico M., Camargos A.F., Petraglia F. Activin, inhibin and the human breast. Mol. Cell. Endocrinol. 2004, 225:77-82.
137. Rifkin D.B. Latent transforming growth factor-beta (TGF-beta) binding proteins: Orchestrators of TGF-beta availability. J. Biol. Chem. 2005, 280:7409-7412.
138. Risbridger G.P., Clements J., Robertson D.M., Drummond A.E., Muir J., Burger H.G., de Kretser D.M. Immuno- and bioactive inhibin and inhibin alpha-subunit expression in rat Leydig cell cultures. Mol. Cell. Endocrinol. 1989, 66:119-122.
139. Rivier J., Spiess J., McClintock R., Vaughan J., Vale W. Purification and partial characterization of inhibin from porcine follicular fluid. Biochem. Biophys. Res. Commun. 1985, 133:120-127.
140. Robert N.M., Miyamoto Y., Taniguchi H., Viger R.S. LRH-1/NR5A2 cooperates with GATA factors to regulate inhibin alpha-subunit promoter activity. Mol. Cell. Endocrinol. 2006, 257-258:65-74.
141. Roberts V.J., Peto C.A., Vale W., Sawchenko P.E. Inhibin/activin subunits are costored with FSH and LH in secretory granules of the rat anterior pituitary gland. Neuroendocrinology 1992, 56:214-224.
142. Roberts V.J., Barth S., el-Roeiy A., Yen S.S. Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. J. Clin. Endocrinol. Metab. 1993, 77:1402-1410.
143. Roberts V.J., Barth S., el-Roeiy A., Yen S.S. Expression of inhibin/activin system messenger ribonucleic acids and proteins in ovarian follicles from women with polycystic ovarian syndrome. J. Clin. Endocrinol. Metab. 1994, 79:1434-1439.
144. Robertson D.M., Foulds L.M., Leversha L., Morgan F.J., Hearn M.T., Burger H.G., Wettenhall R.E., de Kretser D.M. Isolation of inhibin from bovine follicular fluid. Biochem. Biophys. Res. Commun. 1985, 126:220-226.
145. Robertson D.M., Giacometti M., Foulds L.M., Lahnstein J., Goss N.H., Hearn M.T., de Kretser D.M. Isolation of inhibin alpha-subunit precursor proteins from bovine follicular fluid. Endocrinology 1989, 125:2141-2149.
146. Robertson D., Burger H.G., Sullivan J., Cahir N., Groome N., Poncelet E., Franchimont P., Woodruff T., Mather J.P. Biological and immunological characterization of inhibin forms in human plasma. J. Clin. Endocrinol. Metab. 1996, 81:669-676.
147. Robertson D.M., Cahir N., Findlay J.K., Burger H.G., Groome N. The biological and immunological characterization of inhibin A and B forms in human follicular fluid and plasma. J. Clin. Endocrinol. Metab. 1997, 82:889-896.
148. Robertson D.M., Cahir N., Burger H.G., Mamers P., Groome N. Inhibin forms in serum from postmenopausal women with ovarian cancers. Clin. Endocrinol. (Oxf) 1999, 50:381-386.
149. Robertson D.M., Stephenson T., Cahir N., Tsigos A., Pruysers E., Stanton P.G., Groome N., Thirunavukarasu P. Development of an inhibin alpha subunit ELISA with broad specificity. Mol. Cell. Endocrinol. 2001, 180:79-86.
150. Robertson D.M., Stephenson T., Pruysers E., McCloud P., Tsigos A., Groome N., Mamers P., Burger H.G. Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer. J. Clin. Endocrinol. Metab. 2002, 87:816-824.
151. Robertson D.M., Stephenson T., McLachlan R.I. Characterization of plasma inhibin forms in fertile and infertile men. Hum. Reprod. 2003, 18:1047-1054.
152. Robertson D.M., Pruysers E., Jobling T. Inhibin as a diagnostic marker for ovarian cancer. Cancer Lett. 2007, 249:14-17.
153. Saharinen J., Taipale J., Keski-Oja J. Association of the small latent transforming growth factor-beta with an eight cysteine repeat of its binding protein LTBP-1. EMBO J. 1996, 15:245-253.
154. Saito S., Yano K., Sharma S., McMahon H.E., Shimasaki S. Characterization of the post-translational modification of recombinant human BMP-15 mature protein. Protein Sci. 2008, 17:362-370.
155. Salvador L.M., Park Y., Cottom J., Maizels E.T., Jones J.C., Schillace R.V., Carr D.W., Cheung P., Allis C.D., Jameson J.L., Hunzicker-Dunn M. Follicle-stimulating hormone stimulates protein kinase A-mediated histone H3 phosphorylation and acetylation leading to select gene activation in ovarian granulosa cells. J. Biol. Chem. 2001, 276:40146-40155.
156. Schmitt J.F., Millar D.S., Pedersen J.S., Clark S.L., Venter D.J., Frydenberg M., Molloy P.L., Risbridger G.P. Hypermethylation of the inhibin alpha-subunit gene in prostate carcinoma. Mol. Endocrinol. 2002, 16:213-220.
157. Sealfon S.C., Weinstein H., Millar R.P. Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor. Endocr. Rev. 1997, 18:180-205.
158. Seder C.W., Hartojo W., Lin L., Silvers A.L., Wang Z., Thomas D.G., Giordano T.J., Chen G., Chang A.C., Orringer M.B., Beer D.G. Upregulated INHBA expression may promote cell proliferation and is associated with poor survival in lung adenocarcinoma. Neoplasia 2009, 11:388-396.
159. Shacham S., Harris D., Ben-Shlomo H., Cohen I., Bonfil D., Przedecki F., Lewy H., Ashkenazi I.E., Seger R., Naor Z. Mechanism of GnRH receptor signaling on gonadotropin release and gene expression in pituitary gonadotrophs. Vitam. Horm. 2001, 63:63-90.
160. Shi J., Yoshino O., Osuga Y., Koga K., Hirota Y., Hirata T., Yano T., Nishii O., Taketani Y. Bone morphogenetic protein-6 stimulates gene expression of follicle-stimulating hormone receptor, inhibin/activin beta subunits, and anti-Mullerian hormone in human granulosa cells. Fertil. Steril. 2009, 92:1794-1798.
161. Sidis Y., Fujiwara T., Leykin L., Isaacson K., Toth T., Schneyer A.L. Characterization of inhibin/activin subunit, activin receptor, and follistatin messenger ribonucleic acid in human and mouse oocytes: Evidence for activin's paracrine signaling from granulosa cells to oocytes. Biol. Reprod. 1998, 59:807-812.
162. Spencer S.J., Rabinovici J., Jaffe R.B. Human recombinant activin-A inhibits proliferation of human fetal adrenal cells in vitro. J. Clin. Endocrinol. Metab. 1990, 71:1678-1680.
163. Spencer S.J., Rabinovici J., Mesiano S., Goldsmith P.C., Jaffe R.B. Activin and inhibin in the human adrenal gland. Regulation and differential effects in fetal and adult cells. J. Clin. Invest. 1992, 90:142-149.
164. Spencer K., Yu C.K., Savvidou M., Papageorghiou A.T., Nicolaides K.H. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation. Ultrasound Obstet. Gynecol. 2006, 27:658-663.
165. Steinberger A. Inhibin production by Sertoli cells in culture. J. Reprod. Fertil. Suppl. 1979, 26:31-45.
166. Stewart A.G., Milborrow H.M., Ring J.M., Crowther C.E., Forage R.G. Human inhibin genes. Genomic characterisation and sequencing. FEBS Lett. 1986, 206:329-334.
167. Sugino K., Nakamura T., Takio K., Miyamoto K., Hasegawa Y., Igarashi M., Titani K., Sugino H. Purification and characterization of high molecular weight forms of inhibin from bovine follicular fluid. Endocrinology 1992, 130:789-796.
168. Suzuki T., Miyamoto K., Hasegawa Y., Abe Y., Ui M., Ibuki Y., Igarashi M. Regulation of inhibin production by rat granulosa cells. Mol. Cell. Endocrinol. 1987, 54:185-195.
169. Tanimoto K., Handa S., Ueno N., Murakami K., Fukamizu A. Structure and sequence analysis of the human activin beta A subunit gene. DNA Seq. 1991, 2:103-110.
170. Tanimoto K., Yoshida E., Mita S., Nibu Y., Murakami K., Fukamizu A. Human activin betaA gene. Identification of novel 5' exon, functional promoter, and enhancers. J. Biol. Chem. 1996, 271:32760-32769.
171. Thirunavukarasu P., Stephenson T., Forray J., Stanton P.G., Groome N., Wallace E., Robertson D.M. Changes in molecular weight forms of inhibin A and pro-alpha C in maternal serum during human pregnancy. J. Clin. Endocrinol. Metab. 2001, 86:5794-5804.
172. Thirunavukarasu P., Robertson D.M., Dole A., Waldron K., Dawson G., Wallace E.M. Placental, maternal serum and amniotic fluid molecular weight forms of inhibin A and pro-alphaC. Placenta 2003, 24:370-377.
173. Thomas T.Z., Chapman S.M., Hong W., Gurusingfhe C., Mellor S.L., Fletcher R., Pedersen J., Risbridger G.P. Inhibins, activins, and follistatins: Expression of mRNAs and cellular localization in tissues from men with benign prostatic hyperplasia. Prostate 1998, 34:34-43.
174. Tibaldi E., Arrigoni G., Martinez H.M., Inagaki K., Shimasaki S., Pinna L.A. Golgi apparatus casein kinase phosphorylates bioactive Ser-6 of bone morphogenetic protein 15 and growth and differentiation factor 9. FEBS Lett. 2010, 584(4):801-805.
175. Tremblay J.J., Viger R.S. GATA factors differentially activate multiple gonadal promoters through conserved GATA regulatory elements. Endocrinology 2001, 142:977-986.
176. Tsonis C.G., Hillier S.G., Baird D.T. Production of inhibin bioactivity by human granulosa-lutein cells: Stimulation by LH and testosterone in vitro. J. Endocrinol. 1987, 112:R11-R14.
177. Tuuri T., Eramaa M., Hilden K., Ritvos O. The tissue distribution of activin beta A- and beta B-subunit and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development. J. Clin. Endocrinol. Metab. 1994, 78:1521-1524.
178. Uccella S., La Rosa S., Genasetti A., Capella C. Localization of inhibin/activin subunits in normal pituitary and in pituitary adenomas. Pituitary 2000, 3:131-139.
179. van Schaik R.H., Wierikx C.D., Timmerman M.A., Oomen M.H., van Weerden W.M., van der Kwast T.H., van Steenbrugge G.J., de Jong F.H. Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues. Br. J. Cancer 2000, 82:112-117.
180. Vliegen M.K., Schlatt S., Weinbauer G.F., Bergmann M., Groome N.P., Nieschlag E. Localization of inhibin/activin subunits in the testis of adult nonhuman primates and men. Cell Tissue Res. 1993, 273:261-268.
181. Wada M., Shintani Y., Kosaka M., Sano T., Hizawa K., Saito S. Immunohistochemical localization of activin A and follistatin in human tissues. Endocr. J. 1996, 43:375-385.
182. Wakefield L.M., Smith D.M., Flanders K.C., Sporn M.B. Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences. J. Biol. Chem. 1988, 263:7646-7654.
183. Wallace E.M., Swanston I.A., McNeilly A.S., Ashby J.P., Blundell G., Calder A.A., Groome N.P. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. Clin. Endocrinol. (Oxf). 1996, 44:17-21.
184. Wallace E.M., Marjono B., Tyzack K., Tong S. First trimester levels of inhibins and activin A in normal and failing pregnancies. Clin. Endocrinol. (Oxf). 2004, 60:484-490.
185. Walsh S., Metter E.J., Ferrucci L., Roth S.M. Activin-type II receptor B (ACVR2B) and follistatin haplotype associations with muscle mass and strength in humans. J. Appl. Physiol. 2007, 102:2142-2148.
186. Walton K.L., Makanji Y., Wilce M.C., Chan K.L., Robertson D.M., Harrison C.A. A common biosynthetic pathway governs the dimerization and secretion of inhibin and related transforming growth factor beta (TGFbeta) ligands. J. Biol. Chem. 2009, 284:9311-9320.
187. Walton K.L., Makanji Y., Chen J., Wilce M.C., Chan K.L., Robertson D.M., Harrison C.A. Two distinct regions of latency associated peptide coordinate stability of the latent TGF-{beta}1 complex. J. Biol. Chem. 2010, 285:17029-17037.
188. Wang H., Tsang B.K. Nodal signalling and apoptosis. Reproduction 2007, 133:847-853.
189. Wang H., Jiang J.Y., Zhu C., Peng C., Tsang B.K. Role and regulation of nodal/activin receptor-like kinase 7 signaling pathway in the control of ovarian follicular atresia. Mol. Endocrinol. 2006, 20:2469-2482.
190. Welt C.K. Regulation and function of inhibins in the normal menstrual cycle. Semin. Reprod. Med. 2004, 22:187-193.
191. Welt C.K., Schneyer A.L. Differential regulation of inhibin B and inhibin a by follicle-stimulating hormone and local growth factors in human granulosa cells from small antral follicles. J. Clin. Endocrinol. Metab. 2001, 86:330-336.
192. Welt C.K., Smith Z.A., Pauler D.K., Hall J.E. Differential regulation of inhibin A and inhibin B by luteinizing hormone, follicle-stimulating hormone, and stage of follicle development. J. Clin. Endocrinol. Metab. 2001, 86:2531-2537.
193. Welt C.K., Pagan Y.L., Smith P.C., Rado K.B., Hall J.E. Control of follicle-stimulating hormone by estradiol and the inhibins: Critical role of estradiol at the hypothalamus during the luteal-follicular transition. J. Clin. Endocrinol. Metab. 2003, 88:1766-1771.
194. Whitehouse C., Solomon E. Current status of the molecular characterization of the ovarian cancer antigen CA125 and implications for its use in clinical screening. Gynecol. Oncol. 2003, 88:S152-S157.
195. Winters S.J., Plant T.M. Partial characterization of circulating inhibin-B and pro-alphaC during development in the male rhesus monkey. Endocrinology 1999, 140:5497-5504.
196. Woodruff T.K., Meunier H., Jones P.B., Hsueh A.J., Mayo K.E. Rat inhibin: Molecular cloning of alpha- and beta-subunit complementary deoxyribonucleic acids and expression in the ovary. Mol. Endocrinol. 1987, 1:561-568.
197. Woodruff T.K., Besecke L.M., Groome N., Draper L.B., Schwartz N.B., Weiss J. Inhibin A and inhibin B are inversely correlated to follicle-stimulating hormone, yet are discordant during the follicular phase of the rat estrous cycle, and inhibin A is expressed in a sexually dimorphic manner. Endocrinology 1996, 137:5463-5467.
198. Wrana J.L., Attisano L., Wieser R., Ventura F., Massague J. Mechanism of activation of the TGF-beta receptor. Nature 1994, 370:341-347.
199. Yamada Y., Yamamoto H., Yonehara T., Kanasaki H., Nakanishi H., Miyamoto E., Miyazaki K. Differential activation of the luteinizing hormone beta-subunit promoter by activin and gonadotropin-releasing hormone: A role for the mitogen-activated protein kinase signaling pathway in LbetaT2 gonadotrophs. Biol. Reprod. 2004, 70:236-243.
200. Yang Z., Mu Z., Dabovic B., Jurukovski V., Yu D., Sung J., Xiong X., Munger J.S. Absence of integrin-mediated TGFbeta1 activation in vivo recapitulates the phenotype of TGFbeta1-null mice. J. Cell Biol. 2007, 176:787-793.
201. Ying S.Y., Czvik J., Becker A., Ling N., Ueno N., Guillemin R. Secretion of follicle-stimulating hormone and production of inhibin are reciprocally related. Proc. Natl. Acad. Sci. USA 1987, 84:4631-4635.
202. Yndestad A., Ueland T., Oie E., Florholmen G., Halvorsen B., Attramadal H., Simonsen S., Froland S.S., Gullestad L., Christensen G., Damas J.K., Aukrust P. Elevated levels of activin A in heart failure: Potential role in myocardial remodeling. Circulation 2004, 109:1379-1385.
203. Young G.D., Murphy-Ullrich J.E. The tryptophan-rich motifs of the thrombospondin type 1 repeats bind VLAL motifs in the latent transforming growth factor-beta complex. J. Biol. Chem. 2004, 279:47633-47642.
204. Yu A.W., Shao L.E., Frigon N.L., Yu J. Detection of functional and dimeric activin A in human marrow microenvironment. Implications for the modulation of erythropoiesis. Ann. NY Acad. Sci. 1994, 718:285-298. (discussion 298-9).
205. Zawel L., Dai J.L., Buckhaults P., Zhou S., Kinzler K.W., Vogelstein B., Kern S.E. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1998, 1:611-617.
206. Zhang Z.W., Carson R.S., Herington A.C., Lee V.W., Burger H.G. Follicle-stimulating hormone and somatomedin-C stimulate inhibin production by rat granulosa cells in vitro. Endocrinology 1987, 120:1633-1638.